ArticleInternational ophthalmology2024
Refractive outcomes of small lenticule extraction (SMILE) Pro® with a 2 MHz femtosecond laser.
Article in International ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 22 citations in OpenAlex.
- Initial Visual and Refractive Outcomes of Ray-Tracing-Guided LASIK (Wavelight Plus) Versus KLEx (SMILE Pro).Ophthalmology and therapy · 2026Article
- Vector Analysis of High-Astigmatism Correction in Small Incision Lenticule Extraction: A Comparative Study of VisuMax 500 and VisuMax 800.Korean journal of ophthalmology : KJO · 2026Article
- A novel method for evaluating the thickness and keratometry profiles of toric lenticules created by a new-generation keratorefractive lenticule extraction platform.Eye (London, England) · 2026Article
- Clinical outcomes of the new generation VISUMAX 800 platform in small incision lenticule extraction for Myopia in Chinese patients.Scientific reports · 2026Article
- Intraoperative Safety and Postoperative Complications After SMILE Pro: A Retrospective Case Series of 916 Eyes.Journal of clinical medicine · 2026Article
- Three-Month Visual and Refractive Outcomes of Keratorefractive Lenticule Extraction (KLEx) for Myopia and Myopic Astigmatism Using the VISUMAX 800 in 1611 Eyes.Ophthalmology and therapy · 2026Article
- Vector outcomes after SMILE pro with the VISUMAX 800 for high versus moderate-to-low astigmatism: a contralateral eye comparison.Frontiers in medicine · 2026Article
- Enhanced predictability and axis precision of SMILE Pro, a retrospective analysis of myopic astigmatism correction.International journal of ophthalmology · 2026Article
- Association of Treatment Decentration with Early Outcomes Following SMILE Pro: A Secondary Analysis.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Factors Affecting Visual Outcome after Small Incision Lenticule Extraction (SMILE) Pro.Korean journal of ophthalmology : KJO · 2025Article
- Correlation Between Myopia Degree and Postoperative Dry Eye Disease in Keratorefractive Lenticule Extraction Surgery.Cureus · 2025Article
- Comparison of Refractive Outcomes Between Small Lenticule Extraction Using a 500 KHz and a 2 MHz Femtosecond Laser.Diagnostics (Basel, Switzerland) · 2025Article
- The Efficiency, Predictability and Safety Between Custom-Q Femotsecond Laser In Situ Keratomileusis and Second (Visumax 800) Generation Keratorefractive Lenticule Extraction Surgery.Diagnostics (Basel, Switzerland) · 2025Article
- Comparison Between Topographic-Based and Manifest-Based Astigmatism Corrections in the Second (Visumax 800)-Generation Keratorefractive Lenticule Extraction Surgery: A Real-World Study.Diagnostics (Basel, Switzerland) · 2025Article
- Three-Month Outcomes of SMILE Pro with the VISUMAX 800 for Myopic Astigmatism in a Large Population.Clinical ophthalmology (Auckland, N.Z.) · 2025Article
- Initial Visual and Refractive Outcomes of Keratorefractive Lenticule Extraction Using 2MHz Femtosecond Laser Platform.Clinical ophthalmology (Auckland, N.Z.) · 2025Article
- Comparing The Existing Myopic Keratorefractive Lenticule Extraction (KLEx) Platforms: A Narrative Review.Clinical ophthalmology (Auckland, N.Z.) · 2025Review
- Comparison of Visual and Refractive Outcomes Between Refractive Lens Exchange and Keratorefractive Lenticule Extraction Surgery in Moderate to High Myopia.Diagnostics (Basel, Switzerland) · 2024Article
- The outcomes of first-generation (visumax 500) and second-generation (Visumax 800) keratorefractive lenticule extraction surgeries for astigmatism.Scientific reports · 2024Article
- The Risk Factors for Myopia Undercorrection in Second-Generation (Visumax 800) Keratorefractive Lenticule Extraction Surgery: A Retrospective Case-Control Study.Diagnostics (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the initial visual outcomes of Small Incision Lenticule Extraction (SMILE) Pro® using a 2 MHz femtosecond laser (VisuMax 800, Carl Zeiss Meditec) and to assess the efficacy, safety, predictability, accuracy, and complication rate.
methodsThis retrospective analysis included eyes which underwent the SMILE Pro® procedure using VisuMax 800 femtosecond laser to correct myopia. All surgeries were performed by one surgeon (DB). Follow-up was conducted 3 months postoperatively to evaluate visual outcomes after neuroadaptation, corrected visual acuity (CDVA) and intra- and postoperative complications.
resultsOne hundred and fifty-two eyes of 82 patients (mean age 31 ± 6 years) results at 3 months are presented. The mean spherical equivalent (SE) was - 4.44 ± 1.86 D preoperatively while -0.24 ± 0.32 D postoperatively. 99% of eyes achieved SE within ± 1.0 D of attempted correction and 91% were within ± 0.5 D. Efficacy index was 0.93 while the safety index was 1. No complications occurred intra- or postoperatively. No eyes lost more than 1 line of their preoperative CDVA. All highly myopic eyes (- 6.25 to - 10.00 D; n = 18) achieved 20/20 at 3 months postoperatively and were within 0.5 D from the attempted SE and no eyes lost more than 1 line of CDVA.
conclusionThe SMILE Pro® is a safe, efficient, and predictable procedure for the treatment of myopia and myopic astigmatism, with comparable results of conventional SMILE surgery. High myopic eyes achieve better results than low and moderate myopia. No complications were recorded in our patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.